IPP Bureau
Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
By IPP Bureau - March 08, 2022
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
ENTOD Pharmaceuticals launches glaucoma awareness campaign
By IPP Bureau - March 08, 2022
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
Dr Sheela Nampoothiri appointed as co-chair of ICMR's Rare Diseases expert committee
By IPP Bureau - March 08, 2022
Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.
Organon declares paid time off for all employees on International Women’s Day
By IPP Bureau - March 08, 2022
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Suvoda unveils new brand to reflect expanded focus in complex clinical trial management
By IPP Bureau - March 08, 2022
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
Moderna to set up first mRNA facility in Kenya
By IPP Bureau - March 08, 2022
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Ankura launches pharmaceutical data integrity solution
By IPP Bureau - March 08, 2022
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment
By IPP Bureau - March 08, 2022
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
LifeCell India initiative to identify breast cancer risk in women
By IPP Bureau - March 08, 2022
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
American Oncology Institute highlights spirit of women cancer survivors
By IPP Bureau - March 08, 2022
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
Sense receives CE marking for Veros Covid-19 instrument-free molecular test
By IPP Bureau - March 08, 2022
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
GOQii survey points to rise in women medical issues
By IPP Bureau - March 08, 2022
Women's health is in fact a direct reflection of the nation's overall health
Toyobo invests in US-based biotech startup DMC Biotechnologies
By IPP Bureau - March 08, 2022
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
Lonza completes expansion of API manufacturing Lab in Nansha, China
By IPP Bureau - March 08, 2022
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Vantage Specialty Chemicals acquires JEEN
By IPP Bureau - March 08, 2022
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
